Latest news

Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

Orchard Therapeutics Expands US Presence with New Corporate Office in Boston